Musculoskeletal and orthopaedics
Conditions
Interventions
Study design: A multicentre, parallel two-arm feasibility RCT with an embedded qualitative study to explore acceptability.
Timeframe: The study duration will be 24 months. This will include site set-
Sponsors
Oxford University Hospitals NHS Trust
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: 1. Participant is willing and able to give informed consent for participation in the study 2. Male or female, aged 18 years or above 3. Undergoing a single-stage rTHA or the final stage of a multi-stage rTHA 4. Independently mobile (with or without an assistive device)
Exclusion criteria
Exclusion criteria: 1. Planned lower limb surgery within 8 months 2. Conditions or comorbidities that make participation in an exercise programme unsafe (e.g. severe acute or unstable cardiovascular or pulmonary disease,or undergoing radiotherapy or chemotherapy for cancer treatment) 3. Other neurological or medical conditions that would prevent physical measures from being collected
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Recruitment to the study is measured using screening logs at one time point, and numbers eligible, consented and randomised at screening 2. Retention in the study is measured using logs of data collected at baseline, 4 and 8 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Adherence with the intervention is measured using physiotherapy session attendance, retention rate and qualitative interviews 2. Intervention fidelity is monitored by completion of treatment logs and qualitative interviews upon completion of the intervention and interviews. 3. Evaluation of the outcome measures for a full trial is by assessment of completion rate of the patient-reported outcome measures and performance-based outcome measures, and qualitative interviews from patients and physiotherapists, at the end of the study 4. To confirm a definitive primary outcome for a full trial, the completion rate of the expected primary outcome for a future full trial (Oxford Hip Score) will be assessed at the end of the study 5. The experience of participants in the trial and clinicians delivering the intervention will be assessed using qualitative interviews conducted at the end of the intervention period. | — |
Countries
England, United Kingdom
Contacts
Public ContactAlana Morris
Outcome results
None listed